Science Explorer Interactive view Map
Company · Tokyo · Japan

Boehringer Ingelheim (Japan)

boehringer-ingelheim.jpROR OpenAlex
World rank, all time
#14,262
of 42,892
Rank in Japan
#547
of 2,112
Research works
283
▼ 5% vs 2013–17
Citations
9.4k
33.3 per fractional work
Top-10% rate
16.9%
record average 16.5%
Open access
41%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.05× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.22× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 5.40× its world share, 2 worksImmunology and Micro…Neuroscience: 0.92× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 16.17× its world share, 2 worksPharmacology, Toxico…Chemistry: 2.44× its world share, 2 worksChemistryComputer Science: 0.18× its world share, 1 worksComputer ScienceEnergy: 0.28× its world share, 0 worksEnergyEngineering: 0.29× its world share, 2 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.31× its world share, 0 worksMaterials ScienceMathematics: 4.13× its world share, 2 worksMathematicsPhysics and Astronomy: 0.23× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.40× its world share, 0 worksHealth ProfessionsMedicine: 2.60× its world share, 22 worksMedicineVeterinary: 0.28× its world share, 0 worksVeterinaryArts and Humanities: 0.09× its world share, 0 worksArts and HumanitiesDecision Sciences: 2.17× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 1.77× its world share, 2 worksEconomics, Econometr…Psychology: 0.37× its world share, 0 worksPsychologySocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 16.2×. Every wedge is a field page.

Which keywords describe research at Boehringer Ingelheim (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: TGF-ß, Heart Failure, Fibrosis, Glycemic Control, Treatment, Insulin Therapy, Biomarkers and Cardiovascular Disease.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. TGF-ß3▲ 50×3 topics
  2. Heart Failure3▲ 15×5 topics
  3. Treatment3▲ 5.0×9 topics
  4. Fibrosis3▲ 32×3 topics
  5. Epidemiology2▲ 1.42×16 topics
  6. Cardiovascular Disease2▲ 4.8×7 topics
  7. Glycemic Control2▲ 33×4 topics
  8. Quality of Life2▲ 3.4×8 topics
  9. Biomarkers2▲ 7.0×7 topics
  10. Diagnosis2▲ 5.2×12 topics
  11. Insulin Therapy2▲ 39×3 topics
  12. Interstitial Lung Disease2▲ 66×2 topics
  13. Autoantibodies2▲ 16×5 topics
  14. Clinical Guidelines2▲ 14×3 topics
  15. Epithelial-Mesenchymal Transition2▲ 39×2 topics
  16. Immune System2▲ 15×3 topics
  17. Type 2 Diabetes2▲ 16×2 topics
  18. ATP-dependent Transporters1▲ 128×1 topic
  19. Cardiovascular Outcomes1▲ 61×1 topic
  20. Glucose Control1▲ 61×1 topic
  21. IL-171▲ 98×1 topic
  22. Idiopathic Pulmonary Fibrosis1▲ 72×1 topic
  23. Metabolic Regulation1▲ 20×2 topics
  24. Multidrug Resistance1▲ 97×1 topic
  25. Myofibroblast1▲ 72×1 topic
  26. TH17 Cells1▲ 98×1 topic
  27. Bayesian Methods1▲ 57×2 topics
  28. Chronic Kidney Disease1▲ 12×7 topics
  29. Diabetes1▲ 6.0×6 topics
  30. Drug Discovery1▲ 13×3 topics
  31. Pharmacokinetics1▲ 11×2 topics
  32. Clinical Trials1▲ 4.2×6 topics
  33. Medicinal Chemistry1▲ 9.5×5 topics
  34. Adaptive Designs1▲ 123×1 topic
  35. False Discovery Rate1▲ 123×1 topic
  36. Genetic Variation1▲ 12×2 topics
  37. Guidelines1▲ 5.4×4 topics
  38. Cytochrome P4501▲ 70×1 topic
  39. Microfluidics1▲ 31×2 topics
  40. Pharmacogenetics1▲ 117×1 topic

Which research topics does Boehringer Ingelheim (Japan) publish most on?

By volume in 2022–2025: Diabetes Treatment and Management, Drug Transport and Resistance Mechanisms, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Psoriasis: Treatment and Pathogenesis.

Diabetes Treatment and M…1Diabetes Treatment and Management: 1 fractional worksDrug Transport and Resis…1Drug Transport and Resistance Mechanisms: 1 fractional worksInterstitial Lung Diseas…1Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 1 fractional worksPsoriasis: Treatment and…1Psoriasis: Treatment and Pathogenesis: 1 fractional worksStatistical Methods in Clinical Trials: 1 fractional worksPharmacogenetics and Drug Metabolism: 1 fractional worksHealth Systems, Economic…1Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksInnovative Microfluidic …1Innovative Microfluidic and Catalytic Techniques Innovation: 1 fractional worksHeart Failure Treatment …1Heart Failure Treatment and Management: 1 fractional worksChemical Synthesis and A…1Chemical Synthesis and Analysis: 1 fractional works
Endocrinology, Diabetes and MetabolismOncologyPulmonary and Respiratory MedicineImmunology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
  2. 2 Drug Transport and Resistance Mechanisms Oncology 1 works
  3. 3 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
  4. 4 Psoriasis: Treatment and Pathogenesis Immunology 1 works
  5. 5 Statistical Methods in Clinical Trials Statistics and Probability 1 works
  6. 6 Pharmacogenetics and Drug Metabolism Pharmacology 1 works
  7. 7 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  8. 8 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 1 works
  9. 9 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 1 works
  10. 10 Chemical Synthesis and Analysis Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.9%not open59.1%

World: 28% of research is openly available.

with international co-authors63.2%domestic only36.8%

World: 19% is written across borders.

How has Boehringer Ingelheim (Japan)'s research output changed?

Output in 2018–2022 was 5% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.